These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19236251)

  • 1. Applications of monoclonal antibodies for the treatment of hematological malignancies.
    Migkou M; Dimopoulos MA; Gavriatopoulou M; Terpos E
    Expert Opin Biol Ther; 2009 Feb; 9(2):207-20. PubMed ID: 19236251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of CD20 monoclonal antibody therapy in B-cell malignancies.
    Czuczman MS; Gregory SA
    Leuk Lymphoma; 2010 Jun; 51(6):983-94. PubMed ID: 20367564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia.
    Robak T
    Curr Cancer Drug Targets; 2008 Mar; 8(2):156-71. PubMed ID: 18336199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Bello C; Veliz M; Pinilla-Ibarz J
    Expert Rev Clin Immunol; 2011 May; 7(3):295-300. PubMed ID: 21595596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura.
    Milani C; Castillo J
    Curr Opin Mol Ther; 2009 Apr; 11(2):200-7. PubMed ID: 19330725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
    Schriever F; Huhn D
    Drugs; 2003; 63(10):953-69. PubMed ID: 12699399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on obinutuzumab in the treatment of B-cell malignancies.
    Illidge T; Cheadle EJ; Donaghy C; Honeychurch J
    Expert Opin Biol Ther; 2014 Oct; 14(10):1507-17. PubMed ID: 25190612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody-based therapeutics for leukemia.
    Li Y; Zhu Z
    Expert Opin Biol Ther; 2007 Mar; 7(3):319-30. PubMed ID: 17309324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody therapy for chronic lymphocytic leukemia: a promising new modality.
    Lin TS; Moran M; Lucas M; Waymer S; Jefferson S; Fischer DB; Grever MR; Byrd JC
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):895-913, ix-x. PubMed ID: 15325705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the research of anti-CD20 therapeutic monoclonal antibodies].
    Deng CL; Zou J; Song HF
    Yao Xue Xue Bao; 2013 Oct; 48(10):1515-20. PubMed ID: 24417077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
    Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1.
    Siddiqi T; Rosen ST
    Oncology (Williston Park); 2015 Mar; 29(3):198-203. PubMed ID: 25772456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia.
    Laurenti L; De Padua L; D'Arena G; Vannata B; Innocenti I; Tarnani M; Deaglio S; Sica S; Efremov DG; Leone G
    Mini Rev Med Chem; 2011 Jun; 11(6):508-18. PubMed ID: 21561405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Magic bullets"--monoclonal antibodies in acute leukemia and non-Hodgkin's lymphoma treatment].
    Łuczyński W; Krawczuk-Rybak M
    Postepy Hig Med Dosw; 2002; 56(6):789-801. PubMed ID: 12669700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.